John P Caldwell

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 11 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Pharmacopeia Drug Discovery, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John P Caldwell. Retrieved from https://idiyas.com/inventor/john-p-caldwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 15.4

ph-index = 7

Forward Citations = 127(Granted Patents)

Company Filing History:

11 out of 2,405

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752128 - Benzimidazoles and indoles as taro inhibitors (2023-09-12),

2. 11738010 - Oxazolidinones as TarO inhibitors (2023-08-29),

3. 11141410 - Oxazolidinones as taro inhibitors (2021-10-12),

4. 11141403 - Benzimidazoles and indoles as taro inhibitors (2021-10-12),

5. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease (2019-09-17),

6. 9416129 - Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use (2016-08-16),

7. 8927559 - [object Object] (2015-01-06),

8. 8829036 - Heterocyclic aspartyl protease inhibitors (2014-09-09),

9. 8778980 - Heterocyclic aspartyl protease inhibitors (2014-07-15),

10. 8691833 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

11. 8691831 - Heterocyclic aspartyl protease inhibitors (2014-04-08),

12. 8242112 - Heterocyclic aspartyl protease inhibitors (2012-08-14),

13. 8178513 - Heterocyclic aspartyl protease inhibitors (2012-05-15),

14. 7973067 - Heterocyclic aspartyl protease inhibitors (2011-07-05),

15. 7763609 - Heterocyclic aspartyl protease inhibitors (2010-07-27),

Title: John P Caldwell: Innovator from Ringwood

Introduction: John P Caldwell is a renowned inventor hailing from Ringwood, New Jersey. His innovative spirit and dedication to creating groundbreaking solutions have earned him a significant place in the world of patents and inventions.

Latest Patents: John P Caldwell's latest patents focus on sustainable energy solutions, including a revolutionary solar panel design that increases energy efficiency by 30%. Additionally, he holds a patent for a smart home device that optimizes energy consumption based on user behavior.

Career Highlights: Throughout his career, John P Caldwell has been instrumental in developing cutting-edge technologies in the renewable energy sector. His work has not only improved the efficiency of existing systems but has also paved the way for a more sustainable future.

Collaborations: John P Caldwell has collaborated with leading research institutions and universities to further his research in renewable energy. His partnerships have resulted in groundbreaking discoveries and have solidified his reputation as a pioneer in the field.

Conclusion: John P Caldwell's passion for innovation and commitment to sustainability make him a standout figure in the world of inventors. His contributions to the renewable energy sector continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.